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Introduction
Spermatogenesis is an essential process for sexual reproduction in development. It is triggered by the sequential mitotic divisions of spermatogonia, followed by their differentiation into spermatocytes. After two meiotic divisions, spermatocytes develop into spermatids, which possess half the normal complement of genetic material, and then into spermatozoa, mature male gametes in many sexually reproducing organisms. This complex process is controlled by cooperation with several hormones and testicular somatic cells. Follicle-stimulating hormone (FSH) is one of the most important hormones required for early gonadal development, maturity and function (Sairam and Krishnamurthy, 2001) . It is secreted by the pituitary gland and act on testicular somatic cells (Means et al., 1980; Ritzen et al., 1981; Hodgson et al., 1983; Griswold et al., 1988) , mainly Sertoli cells, through the specific receptor. Sertoli cells have essential roles in the regulation of spermatogenesis. They not only represent the only cellular component of the blood-testis barrier but also produce and secrete local factors to germ cells (Dym et al., 1997) .
In mammalian testis, Sertoli cells have been shown to synthesize stem cell factor (SCF) (Motro et al., 1991; Tajima et al., 1991) , which plays a pivotal role in survival (Packer et al., 1995; Yan et al., 2000) , proliferation and differentiation (Yoshinaga et al., 1991; Sette et al., 2000) of germ cells expressing the receptor c-kit (Manova et al., 1990; Sorrentino et al., 1991) . Insulin-like growth factor-I (IGF-I) is another factor shown to act specifically on spermatogonia and primary spermatocytes of rainbow trout (Loir and Le Gac, 1994) . The mRNAs for IGF-I and its receptors are present to a greater extent in Sertoli cell-enriched populations and in those containing spermatogonia and primary spermatocytes (Le Gac et al., 1996) . These findings may define SCF and IGF-I as paracrine factors derived from Sertoli cells in the regulation of spermatogenesis.
In newt testis, we have demonstrated that FSH alone is sufficient to stimulate spermatogonial proliferation and differentiation into primary spermatocytes through the receptor expressed on Sertoli cells in both organ and reaggregate cultures (Abé and Ji, 1994; Abé , 2004) , but not in the culture of spermatogonia alone (Ito and Abé , 1999) . In addition, we reported that SCF and IGF-I, both of which are upregulated in response to FSH (unpublished data; Yamamoto et al., 2001) , induce spermatogonial proliferation (Abé et al., 2002) and differentiation (Nakayama et al., 1999) , respectively, in the organ culture. Recently, we have demonstrated that the blood-testis barrier formed by Sertoli cells show size selectivity, which allows small molecules ($500 Da) to penetrate into the cyst, but not larger ones (>1.9 kDa) in the organ culture (Jin et al., 2008) . Therefore, SCF and IGF-I induce spermatogonial proliferation and differentiation indirectly in the organ culture. Though it is thus considered that the FSH effects are necessary to be mediated by local paracrine factors, which are secreted from Sertoli cells and act directly on spermatogonia within the testis, such factors have not been identified yet.
Because of the complex anatomical organization of the germinal compartment in mammalian testis (the Sertoli cells are normally associated with four or five germ cell generations), it is difficult to examine the stage-specific effects of the regulatory factors in the organ culture (Yamamoto et al., 2001) . In contrast, clonally derived germ cells are enclosed in a cyst, the smallest unit of the testis, and surrounded by Sertoli cells within the lobules in newt testis (Callard, 1991; Abé , 2004) . Therefore, newt testis is an appropriate model to isolate germ cells at a specific stage and study the effect of various factors on specific stage of spermatogenesis.
We aimed to identify FSH-upregulated local factors exerted directly in spermatogonial proliferation and differentiation. To this end, an EST (Expression Sequence Taq) library containing 5321 clones was prepared from newt testes and differentially screened by microarray analysis. We identified neuregulin 1, termed as newt neuregulin 1 (nNRG1), as one of the novel FSH-upregulated clones and isolated partial cDNAs encoding two different clones (newt immunoglobulin (nIg)-type and newt cysteine-rich domain (nCRD)-type). First, we examined their expressions in spermatogenic stages and testicular cell types by semi-quantitative and quantitative RT-PCR. Next, we tested the effects of nNRG1 on spermatogonial proliferation with recombinant epidermal growth factor (EGF)-like domain of nNRG1 (nNRG1-EGF) in organ culture and reaggregated culture with or without somatic cells. The data indicate that nNRG1 plays a pivotal role in promoting spermatogonial proliferation by acting both directly and indirectly via somatic cells on spermatogonia in newt testis.
Results

cDNA cloning and structure of nNRG1 isoforms
To screen out FSH-upregulated genes, we performed microarray analyses of a cDNA library including 5321 independent clones isolated from newt testis containing spermatogonial and early primary spermatocyte stages, and hybridized them with cDNA synthesized from total RNA extracted from testes 48 h after FSH or vehicle injection. NRG1 was identified as one of the 61 FSH-responsive cDNA clones. Nucleotide sequencing revealed that the clone contained an approximately 637 bp cDNA with 74% identity to mouse NRG1 belonging to members of the NRG family conserved among mammals (Falls, 2003) and amphibians (Yang et al., 1998 (Yang et al., , 1999 . RT-PCR analysis confirmed that the mRNA expression of NRG1 gene was induced by FSH at the spermatogonial stages of newt testis (data not shown). Therefore we referred to the clone as newt NRG1 (nNRG1).
As the single NRG1 gene produces many isoforms (Burden and Yarden, 1997; Buonanno and Fischbach, 2001; Falls, 2003) , we aimed to isolate the cDNAs encoding nNRG1 clones in the newt testis. PCR was performed with primers based on the sequences in the extracellular domain of Xenopus laevis Ig-type and CRD-type NRG1. Using newt testes cDNA as a template, two different clones of approximately 500 bp were obtained.
Cloning and sequence analysis of the clones revealed that the first clone was 483 bp in length, including several domains such as the Ig domain and EGF-like domain that was characterized as NRG1 Ig-type isoform of Xenopus laevis (Fig. 1A ) (Yang et al., 1998) . The domains in Ig-like molecules are grouped into four types: variable (V-type), constant-1 (C-1 type), constant-2 (C-2 type) and intermediate (I-type) (Smith and Xue, 1997) . The spacing of the cysteine residues fits the consensus for an Ig-like domain of C2 type (Yang et al., 1998) . The EGF-like domain is well defined with its six cysteine residues which form three disulfide bonds. Two types of EGF-like domains have been identified, a and b, which differ in the amino acid sequences between the 5th and 6th cysteine and in the region carboxyl-terminal to the 6th cysteine (Holmes et al., 1992) . In this clone, the EGF-like domain was a b subtype and identical to the Xenopus laevis b2 type EGF-like domain. There was a spacer domain between Ig-like and EGFlike domains. The spacer domain without any amino acid insertions, namely SP0 (Yang et al., 1998) , was rich in serine and threonine, and two potential N-linked glycosylation sites were just upstream from the spacer domain (Fig. 1A) .
The second clone was 696 bp in length, including a cysteine-rich domain at the N-terminal region that has been characterized as NRG1 CRD-type isoform of Xenopus laevis (Fig. 1B) (Yang et al., 1999) . The amino acid sequence of the EGF-like domain was identical with the first product. The spacer domain between the CRD and EGF-like domain had 43 amino acid insertions, namely SP43 (Yang et al., 1999) , and it was rich in serine and threonine residues, which are potential sites for O-linked glycosylation. Potential N-glycosylation sites were absent (Fig. 1B) .
Comparison of amino acid sequence of nNRG1 clones with other reported NRG1 isoforms showed that nIg-NRG1 was $75% identical to Xenopus laevis Ig-NRG1. The partial sequence of the first clone showed $57% identity to human and 44-48% identities to mouse, chick and rat counterparts. The amino acid sequence of the second clone was $94% identical to Xenopus laevis CRD-NRG1, but it showed only 49-53% identity to that of human (49%), mouse (50%), rat (50%), and chick (53%). The cysteine-rich domain was highly conserved among human, rat, and chick with over 80% amino acid identity. The b2 type EGF-like domain and the spacer domain between the CRD and EGF-like domain was identical to the Xenopus one, but distinct from those of other species. Therefore we referred to the first and second clone as newt Ig-NRG1 (nIg-NRG1) and newt CRD-NRG1 (nCRD-NRG1) isoforms, respectively.
mRNA expression of nNRG1 isoforms in newt testis
To determine mRNA expression of nIg-NRG1 and nCRD-NRG1 during spermatogenesis, semi-quantitative and quantitative RT-PCR was performed using the mRNA derived from various spermatogenic stages, rich in early (3rd-4th) spermatogonia, late (6th-7th) spermatogonia and primary spermatocytes ( Fig. 2A and B) . mRNA expressions of both nIg-NRG1 and nCRD-NRG1 were highly detected at spermatogonial stages than that of primary spermatocyte stage. Noticeably, nIg-NRG1 expression was remarkably high in the late spermatogonial stage.
To examine the effect of FSH on the mRNA expression of two isoforms in different cell types, the fractionated testicular cells were treated with FSH and then RT-PCR analyses were performed ( Fig. 2C and D) . nCRD-NRG1 mRNA was constitutively expressed both in the spermatogonial and somatic cell fractions and its expression level was barely affected by FSH. On the other hand, nIg-NRG1 mRNA was expressed predominantly in the somatic cell fraction and the expression level was remarkably higher in FSH-treated testis than those of non-treated (Fig. 2C and D) . This result indicates that FSH increases nIg-NRG1 mRNA expression in somatic cells.
Effect of FSH on the expression of nIg-NRG1 protein in different cell types
To demonstrate the expression of nIg-NRG1 protein in different cell types, we used the antibody produced against the nIg-NRG1 peptide (Fig. 1A, overlined) . The specificity of the antibody was examined by immunoblotting of the ovalbumin-conjugated nIg-NRG1 (nIg-NRG1-OVA) and nCRD-NRG1 (nCRD-NRG1-OVA) peptides. The nIg-NRG1-OVA peptide was observed using the nIg-NRG1 antibody, where nCRD-NRG1-OVA was not detected (Fig. 3A) . The expression of the nIg-NRG1 protein was demonstrated in somatic cells and the expression was increased by in vitro FSH treatment (Fig. 3B) . Preincubation of the antibody with the antigen peptide blocked the signals ( Fig. 3A and B lower panel).
Effect of recombinant nNRG1 on spermatogonial proliferation in vitro
Since the EGF-like domain of NRG1 is alone sufficient for binding and activating receptors to induce cellular responses (Holmes et al., 1992; Wen et al., 1994) , various concentrations of recombinant EGF-like domain of nNRG1 (nNRG1-EGF) were added to various culture systems to determine the role of nNRG1 in spermatogonial proliferation. In organ culture, testicular fragments were cultured for 1 week and the proliferative activity of spermatogonia was characterized (Fig. 4) . Addition of nNRG1-EGF increased the number of BrdU-positive germ cells in a concentration-dependent manner up to 350 nM, whereas 700 nM did not show any significant difference compared to 350 nM. This result indicates that nNRG1 promotes spermatogonial proliferation indirectly through somatic cells, because nNRG1-EGF could not have worked on germ cells directly due to size-selective barrier formed by Sertoli cells that enclose germ cells in a cyst (Jin et al., 2008) .
Hence, to expose germ cells to nNRG1-EGF directly, we performed reaggregate cultures, in which size-selective barrier was destroyed by dissociation of testis with collagenase treatment (Ito and Abé , 1999; Jin et al., 2008) (Fig. 5A ). After 1 week, both nNRG1-EGF and FSH stimulated spermatogonial proliferation to larger extent than in controls, indicating that nNRG1-EGF can promote spermatogonial proliferation directly and/or through activation of somatic cells (Fig. 5B ).
To reveal whether nNRG1-EGF acts on spermatogonia directly or indirectly via somatic cells, it was added in reaggregated culture of purified spermatogonia (Fig. 5C ). FSH had little effect on promoting spermatogonial proliferation, verifying that percentage of the contaminated Sertoli cells was very low. On the other hand, nNRG1-EGF remarkably stimulated spermatogonial proliferation (Fig. 5D ). Thus nNRG1-EGF was demonstrated to stimulate spermatogonial proliferation directly.
2.5.
Effect of nNRG1 antibody on the spermatogonial proliferation induced by nNRG1 and FSH FSH induces newt spermatogonial proliferation and their differentiation through its receptor expressed on Sertoli cells (Abé , 2004) . In order to examine whether FSH promotes spermatogonial proliferation by activating Sertoli cells to produce nNRG1, antibody against EGF-like domain of nNRG1 (antinNRG1-EGF) was added to the reaggregated culture of testicular cells. The specificity of the antibody was first examined by immunoblotting and shown that it reacted with nNRG1-EGF protein but not un-related protein (Fig. 6A) . Preincubation of the antibody prevented the stimulatory effect by nNRG1-EGF, while normal mouse IgG did not show any significant effect, verifying that the antibody specifically inhibits the action of nNRG1-EGF. In addition, the antibody also inhibited the spermatogonial proliferative activity stimulated by FSH, whereas it did not suppress the activity in the absence of FSH (Fig. 6B ). These results demonstrate that FSH promotes spermatogonial proliferation by activating Sertoli cells to produce nNRG1, at least partly.
Discussion
In newt testis, FSH induces spermatogonial proliferation and their differentiation by binding its receptor expressed on Sertoli cells (Abé , 2004) . We identified newt orthologue of NRG1 as one of the downstream genes using an EST library whose expressions were upregulated by FSH with microarray analyses. NRG belongs to EGF family which is highly conserved among vertebrates (Falls, 2003; Harris et al., 2003) . EGF family proteins play an important role not only in proliferation and differentiation of somatic cells during development, but also in those of germ cells during gametogenesis in many species (Gilboa and Lehmann, 2004; Shilo, 2006) . The present results show: (1) cDNAs for two clones of nNRG1, nIg-type and nCRD-type, were isolated; (2) mRNA for both types of nNRG1 is expressed in spermatogonial stage, but The value of the control was taken as 1.0. * P < 0.05. scarcely in primary spermatocyte stage; (3) mRNA for nIg-NRG1 is highly expressed in somatic cells, very probably Sertoli cells, and the expression is upregulated by FSH, while that for CRD-type is expressed both in somatic and germ cells and is barely dependent on FSH; and (4) nNRG1 stimulates the proliferation of spermatogonia in organ and reaggregate cultures with somatic cells as well as in cultures containing purified spermatogonia. These data suggest that nNRG1 functions as an autocrine factor indirectly via Sertoli cells in a FSH-dependent manner and as a paracrine factor directly, resulting in promoting spermatogonial proliferation in newt testis.
cDNA cloning by RT-PCR detected two clones potentially encoding the amino acid sequences highly homologous to the extracellular domains of X. laevis Ig-type and CRD-type NRG1 which are different in their N-terminal region (Ig-domain and CRD, respectively) but same in their EGF-like domain (b-type). The single NRG1 gene is well known to produce various isoforms generated by alternative splicing in mouse, chick and frog (Yang et al., 1998; Buonanno and Fischbach, 2001; Falls, 2003) . To date about 12 distinct isoforms have been reported in X. laevis based on the N-terminal region, the spacer domain, and the type of EGF-like domain (Yang et al., 1998 (Yang et al., , 1999 . Therefore, our two clones are suggested to be isoforms, nIg-NRG1 and nCRD-NRG1, produced from the single gene by alternative splicing. Comparison of the spacer domain and EGF-like domain of our clones to the X. laevis isoforms indicated that our first clone is Ig-NRG1 SP0 b2 (Yang et al., 1998) and the second one is CRD-NRG1 SP43 b2 (Yang et al., 1999) in newt. b-type EGF-like domain, which is 10-100 times more potent than a-type in most assays (Falls, 2003) , is prevalent in the nervous system, whereas atype is found in mesenchyme (Meyer and Birchmeier, 1994) . Interestingly, since b2 type EGF-like domain is well known to bind and activate receptors and induce cellular responses (Holmes et al., 1992; Wen et al., 1994) , it was shared in both nIg-and nCRD-NRG1 suggested that EGF-like domain is important for signaling and therefore, both isoforms probably play a pivotal role in spermatogonial proliferation and differentiation. However, differential expression of two isoforms in cell types and FSH-dependence may suggest an important role for the Ig-domain and CRD in determining the cell types where the isoform acts on. That may be why two isoforms exist potentially in newt testis. Indeed, previous studies using targeted mutations (Wang et al., 2001; Falls, 2003) showed that CRD-type (type III) and Ig-type (type I) NRG1 have different cell biological properties in vivo: Ig-NRG1 À/À mice die at E10.5 and show defects in cardiac, cranial sensory neuronal and sympathetic development (Kramer et al., 1996; Meyer et al., 1997; Britsch et al., 1998) , but normal development of Schwann cell precursors (Meyer et al., 1997) . On the other hand, CRD-NRG1 À/À mice die at birth because of the defects in neuromuscular synapses and unlike Ig-NRG1
À/À , they have normal heart development but show degeneration of peripheral and cranial nerves (Wolpowitz et al., 2000) . In addition, another study demonstrates that two isoforms, which are different only in their N-terminal (Ig and CRD) sequence, undergo distinct proteolytic processing (Wang et al., 2001 ): Ig-NRG1 is synthesized as a transmembrane proprotein which is proteolytically cleaved to produce a soluble N-terminal fragment containing the bioactive EGF-like domain, whereas CRD-NRG1 remains as a transmembrane protein even after cleavage by proteases. Thus, in contrast to CRD-NRG1 that may act as a cell surface signaling molecule (a juxtacrine factor), Ig-NRG1 may act as a secreted molecule (a paracrine factor) (Wang et al., 2001) . At neuromuscular synapses motor neuron-derived Ig-NRG1 has been the leading candidate for the signal that activates acetylcholine receptor synapse-specific transcription (Rimer, 2003) , while neuronal-derived CRD-NRG1 is a critical primary signals for survival for terminal Schwann cells (Wolpowitz et al., 2000) . These findings suggest that nIg-NRG1 is specialized for FSH-dependent paracrine signaling, whereas nCRD-NRG1 is specialized for juxtacrine (direct-contact) signaling for cell-cell communication in newt testis.
To determine the function of nNRG1 on spermatogonial proliferation in newt testis, we examined the effect of the recombinant EGF-like domain of nNRG1 (nNRG1-EGF) in various culture systems, because it was reported that the EGF-like domain is alone sufficient for binding receptors and induces cellular responses (Holmes et al., 1992; Wen et al., 1994) . The results obtained from the organ culture of testicular fragment showed that nNRG1-EGF enhanced the proliferation of spermatogonia by acting indirectly on them, because macromolecules such as nNRG1-EGF do not penetrate into testicular cysts (Jin et al., 2008) , suggesting nNRG1 could function as an autocrine factor. Therefore, nNRG1 may stimulate the pro- Reaggregates consisting of somatic and germ cells were cultured for 1 week at 18°C in the medium containing none (control), FSH (200 ng/ ml), or nNRG1-EGF (350 nM) with (+) or without (À) nNRG1-EGF antibody (2.5 lg/ml) or normal mouse IgG (2.5 lg/ml). The effect of antibody on spermatogonial proliferation was represented as mean ± SEM of the percentage of BrdU-positive germ cell number obtained from three independent experiments. The value of the control was taken as 1.0. * P < 0.05. duction of other growth factor(s) that activate spermatogonial proliferation in somatic cells. One candidate for the growth factor is SCF, because we found that it is expressed in newt testis (Abe et al., in preparation) . Reaggregated cultures of spermatogonia with somatic cells, where the barrier of Sertoli cells is destroyed, could circumvent the drawback in organ cultures mentioned above. In this system, nNRG1 as well as FSH did stimulate spermatogonial proliferation, suggesting that nNRG1 activates spermatogonia directly and/or indirectly through somatic cells. The addition of nNRG1 to reaggregated cultures of purified spermatogonia directly stimulated their proliferation, suggesting that nNRG1 could function as a paracrine factor. These indirect and direct actions of nNRG1 on newt spermatogonia are consistent with reports in mammals. In rat testis, the receptors for NRG1, ErbB-3 and ErbB-4, are predominantly expressed in Sertoli cells and recombinant human NRG1-a and NRGI-bstimulate the production of transferrin and androgen-binding protein by Sertoli cells (Hoeben et al., 1999) . Recently, NRG1 is identified as a factor required for the formation of rat type Aaligned (Aal) spermatogonia up to the 32-cell stage in a glial cell line-derived neurotrophic factor (GDNF)-dependent manner in culture system (Hamra et al., 2007) . In addition to this, NRG1 receptors are shown to be also expressed in the spermatogonia, suggesting that NRG1s do have the potential to directly stimulate the proliferation of undifferentiated spermatogonia by binding to their receptors (Hamra et al., 2007) . In newt testis, ErbB4 and other ErbB family receptor ErbB2, known to form hetero-dimer with ErbB4 after NRG1 binding, are expressed in both Sertoli and germ cells at all spermatogenic stages and in contrast to ErbB2, the expression of ErbB4 is more abundant at the spermatogonial stages than in the primary spermatocyte stage, indicating that nNRG1 and its receptor ErbB4 show similar expression patterns in spermatogenetic stages in newt testis.
Addition of FSH alone in vivo and in vitro can stimulate newt spermatogonial proliferation and their differentiation into primary spermatocytes by activating its receptor expressed on Sertoli cells (Abé , 2004) . What factors produced by Sertoli cells downstream of FSH might stimulate spermatogonial proliferation and their differentiation into primary spermatocytes? Our current study strongly suggests that one of such factors is nIg-NRG1 because it is highly upregulated by FSH and the stimulative effect of FSH on spermatogonial proliferation was significantly suppressed by the antibody against nNRG1-EGF in reaggregate culture. However, the antibody did not inhibit the effect of FSH completely, which may indicate the involvement of other growth factors such as SCF. Whether nNRG1 alone or in combination with other factors can induce the differentiation of spermatogonia into primary spermatocytes remains to be clarified.
In adult organism, reproduction is one of the most intriguing aspects of development. Improvement to our knowledge on the molecular basis of spermatogenesis could lead to treatments for male fertility. In this point, our finding that FSH induces the expression of nIg-NRG1 in Sertoli cells and recombinant nNRG1 can promote spermatogonial proliferation by acting directly on spermatogonia as well as through somatic cells may help to pave the way for understanding the mechanism of spermatogenesis.
4.
Experimental procedures
Animals and reagents
Adult male newts, Cynops pyrrhogaster, purchased from a dealer (Hamamatsu Seibutsu Kyozai, Hamamatsu, Japan), were kept at 7°C in the dark. Newts to be used for experiments were transferred to 22°C and fed frozen Tubifex. All chemicals were obtained from Nacalai Tesque, Kyoto, Japan, unless otherwise stated.
4.2.
cDNA microarray analysis, cDNA cloning, and RT-PCR Total RNA was extracted from newt testes containing the stages of spermatogonia and early primary spermatocytes by homogenization in ISOGEN (Nippon Gene) using a Dounce homogenizer. cDNA was reverse transcribed with oligo-d(T) primers and random hexamers by a reverse transcriptase Superscript III (Invitrogen).
We made the microarrays carrying 5321 independent cDNA clones and hybridized them with Cy3-or Cy5-labeled cDNA probes prepared from total RNA (CyScribe First Strand cDNA Labeling kit, GE Healthcare), which had been extracted from the testes of newts injected with FSH or vehicle, respectively. Fluorescent signals were quantified by ScanArray 4000 (GE Healthcare), and the data were analyzed by using Quant Array software (GE Healthcare). The cDNA clone (637 bp) encoding NRG1 was isolated and the nucleotide sequence was determined with an Applied Biosystems model 310 automated DNA sequencer.
The cDNA clones encoding nIg-NRG1 and nCRD-NRG1 in newt testis were isolated by reverse transcription of total RNA, and subsequent PCR amplification (RT-PCR). PCR was performed with ExTaq polymerase (Takara) in the condition for 45 cycles at 94°C for 30 s, 60°C for 30 s, 72°C for 45 s, and for 40 cycles at 94°C for 30 s, 58°C for 30 s, 72°C for 45 s, using reverse transcribed cDNA as a template with a sense primer (5 0 -CCAAAACTAAAAGAAATCAAGACTCAG-3 0 and 5 0 -AACTCTGAGAAGATTTGCATAATCCCT-3 0 ) and an antisense primer (5 0 -TTACGTCTACGGCCAATA-3 0 and 5 0 -CAG-TTACGTCTACGGCCAATACC-3 0 ) based on the nucleotide sequence of X. laevis Ig-NRG1a1 (GenBank Accession No: AF076618) and CRD-NRG1b2 (GenBank Accession No: AF142632) reported by Yang et al. (1998 Yang et al. ( , 1999 . Each of the amplified DNA fragments was inserted into pT7Blue vector (Novagen). mRNA expression of nNRG1 isoforms was analyzed by RT-PCR using reverse transcribed cDNA from total RNA of the testis with random hexamers. PCR was performed for 45 cycles at 60°C annealing temperature for nIg-NRG1 and for 45 cycles at 58°C annealing temperature for nCRD-NRG1 with a sense and antisense primer specific for each isoform as follows: nIg-NRG1, 5 0 -CCAAAACTAAAAGAAATCAAGACTCAG-3 0 and 5 0 -GTTGCTGCTTGTTATACCGTT-3 0 ; nCRD-NRG1, 5 0 -AACTCT GAGAAGATTTGCATAATCCCT-3 0 and 5 0 -GGTGTCACCCCTTT TGGTTG-3 0 . Each of the amplified DNA fragments was analyzed by 2% agarose gel electrophoresis, and then inserted into pT7Blue vector (Novagen). The nucleotide sequences were verified by sequencing to show specificity. Negative controls were performed in the RT-PCR reaction mixture without reverse transcriptase. The PCR primers were purchased from Hokkaido System Science Co., Ltd., Japan.
Separation of cells at specific stage by laser microdissection (P.A.L.M.)
Approximately 10 cysts (about 200 cells) each with the 3rd-4th generation of early spermatogonial (EG), the 6th-7th generation of late spermatogonial (LG) and primary spermatocytes (PC) stage in frozen sections (10 lm) were dissected from newt testicular fragments using laser microdissection system (P.A.L.M. microlaser, Carl Zeiss).
4.4.
Real-time quantitative PCR The amounts of target genes expressed in a sample are normalized with housekeeping gene EF1-a as an internal control, which is given by DC t . DC t is determined by subtracting the average endogenous gene C t value from the average target gene C t value. The calculation of DDC t involves subtraction of DC t value for the cases. 2 ÀDDCt is the relative expression of the target genes in cases compared to controls. Three independent experiments data are statistically analyzed by student t test.
Expression plasmids, poly(histidine) fusion protein and antibodies
To express the recombinant protein of the b-type EGF-like domain of nNRG1 as a poly(histidine) fusion protein in bacterial cells, the cDNA encoding amino acid residues 103-161 (nIg-NRG1) was amplified by PCR at 45 cycles at 94°C for 30 s, 58°C for 30 s, and 72°C for 45 s using the isolated cDNA inserted in pT7Blue vector as a template with a sense and an antisense primer 5 0 -CATATGACAGCTGGGCCAGGTCAC-3 0 and 5 0 -ATGGCCAGCTTCTACAAATAA GGATCC-3 0 designed to provide the PCR product with a NdeI restriction site at the 5 0 -end and a BamHI restriction site at the 3 0 -end. The PCR product was digested by the restriction enzymes and then ligated into a bacterial expression vector pET16b (Novagen) to construct the expression plasmids for nNRG1. Bacterial cells (Escherichia coli, BL21 (DE3) strain) carrying the expression plasmid were precultured in LB medium containing 50 lg/ml ampicillin at 37°C overnight. The culture (0.5 ml) was added into 100 ml LB medium containing 50 lg/ ml ampicillin and incubated at 37°C to 0.5 of the absorbance at 600 nm, and then 1 mM isopropyl-1-thio-b-D-galactopyranoside was added. After further 3 h culture, the bacterial cells were harvested by centrifugation at 4°C. The poly(histidine)-tagged fusion protein was affinity purified in a denaturing condition (8 M urea in binding buffer) by nickel resin (250 ll, Invitrogen) column chromatography according to the manufacturer's instructions. For proliferation assay, nNRG1-EGF eluted with 400 mM and 500 mM imidazole was refolded by dialysis against 50 volumes of 20 mM Tris, pH 8.5, 0.1 mM DTT for 6 h at 4°C and for additional 6 h against 20 mM Tris, pH 8.5 (without DTT). To allow the formation of three native disulfide bridges of EGF-like domain, nNRG1 was dialyzed overnight against a redox refolding buffer containing 20 mM Tris, pH 8.5, 1 mM GSH and 0.2 mM GSSG (Mautino et al., 2004) . For producing antibody, nNRG1-EGF was dialyzed overnight against PBS (pH 7.5). Protein concentration was determined by Bio-Rad DC Protein Assay Kit according to the manufacturer's instructions using bovine serum albumin as a standard.
To produce polyclonal antibody against EGF-like domain and nIg-NRG1, purified poly(histidine)-tagged fusion peptide and a peptide corresponding to 14 amino acids from residues 47 to 60 (part of Ig-like domain) conjugated with keyhole limpet hemocyanin (KLH) (Invitrogen) were used, respectively. Two hundred microgram of the peptide was used per once to immunize one mouse (C57BL/6 strain). The mice were injected with four booster injections at 7-day intervals.
For the purification of the antibodies, the antiserum against nNRG1-EGF was mixed with recombinant nNRG1-EGF protein to absorb the antibody against EGF-like domain and to remove non-specific antibodies that might have been generated by contamination during the purification of the recombinant protein. The mixed solution was incubated overnight at 4°C, centrifuged at 15,000g for 1 h and collected supernatant was applied to protein G Sepharose (GE Healthcare) for further purification.
The antisera against nIg-NRG1 was applied to a NHS-activated HiTrap column (GE Healthcare), previously coupled with KLH protein (Calbiochem, Germany), to remove anti-KLH antibody and the collected flowthrough fraction was purified by affinity chromatography on an aldehyde-activated Cellufine Formyl column (Chisso Corporation, Japan) previously coupled with the peptide. Both nNRG1-EGF and nIg-NRG1 antibodies were eluted with 0.1 M Gly-HCl (pH 2.5) and neutralized with 1 M Tris-HCl (pH 9.0).
SDS-PAGE and immunoblotting
Fractionated germ cells and somatic cells were homogenized in extraction buffer (0.2% Nonidet P-40, 20 mM TrisHCl (pH 8.0), 150 mM NaCl, protease inhibitors (protease inhibitor cocktail, Roche) and 1 mM phenylmethylsulfonyl fluoride) using a Dounce homogenizer. After centrifugation at 15,000g for 15 min at 4°C, each extract (20 lg) was mixed with sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 1970) sample buffer (62.5 mM Tris-HCl, pH 6.8, 25% glycerol, 2% SDS, 0.01% bromophenol blue, and 5% b-mercaptoethanol) followed by SDS-10% PAGE and transferred to a polyvinylidene difluoride (PVDF) membrane (Immobilon-P, Millipore). The membrane was blocked in PBS containing 5% skim milk and 0.1% Tween-20 for 1 h at room temperature. Anti-nIg-NRG1 and anti-nNRG1-EGF absorbed with or without 250 lg and 400 lg peptide antigens, respectively, were used at 1:500 dilutions. Anti-His-tag antibody (GE healthcare) was used at 1:200 dilutions. HRP-conjugated anti-mouse IgG (GE Healthcare) was used as a secondary antibody at 1:2000 dilutions. Proteins were detected using an enhanced chemiluminescence reagent (ECL; GE Healthcare).
4.7.
Organ culture, reaggregate culture of germ cells with somatic cells, fractionation of germ cells and somatic cells, and reaggregate culture of germ cells only Organ culture of testicular fragments containing only spermatogonial stage was performed as described before (Abé et al., 2002) . Four fragments of the testes were placed on each nucleopore filter (Coaster, Cambridge, MA). These testicular fragments were cultured for 1 week at 18°C in 2 ml L-15 medium supplemented with 0.1% BSA, and with or without 0.2 lg/ ml of porcine FSH (National Hormone & Peptide Program, Harbor-UCLA Medical Center, CA), and with or without various concentrations of nNRG1-EGF. The culture medium was changed once a week.
Reaggregate cultures of germ and somatic cells were performed according to Ito and Abé (1999) . Testes were dissociated by 0.1% collagenase (type N-2, Nitta Zaratin Co., Japan) for 2 h at 22°C. The cell suspension was filtrated through a 50 lm nylon mesh filter, and dead cells and reticulocytes were removed by centrifugation at 100g for 10 min in 25% Nycodenz solution on which dissociated cells were overlayered. The live cells remaining on the 25% Nycodenz solution were recovered and washed in L-15. The dissociated cells were reaggregated by rotation culture (70 rotations/min, R-30, TAI-TEC, Japan) for 1.5 h at 20°C, followed by centrifugation in a 0.5 ml siliconized tube (Assist, Japan) (3-5 · 10 5 cells/tube) at 100g for 5 min. The cell pellet formed was carefully recovered and put into a collagen (Cellmatrix type I-P, Nitta Zaratin Co., Japan, 2.4 mg/ml) in 1 · L-15 at pH 7.4. The collagen solution containing a reaggregate was then placed on a nucleopore filter for 1 h until collagen hardened and the filter was floated on L-15 medium as organ culture. To see the effect of the antibody against nNRG1-EGF on spermatogonial proliferation in reaggregate culture of spermatogonia with somatic cells, the cultures were preincubated with or without nNRG1-EGF antibody (2.5 lg/ml) or normal mouse IgG (2.5 lg/ml) for 1 day before addition of FSH or nNRG1-EGF.
For analysis of cell type-specific expression of NRG mRNA and protein, germ cells were separated from somatic cells (mostly Sertoli cells) as described above. After recovering the live cells remaining on the 25% Nycodenz solution they were put into a 150 mm plastic culture dishes (#1013, Falcon) that had been coated with 0.3 mg/ml collagen (the original solution was diluted 10 times with sterile water) at 1 · 10 6 cells/dish in 5 ml L-15 medium with 0.1 mM EGTA and 0.1% BSA. When the culture dishes were placed in a incubator at 18°C overnight, somatic cells adhered to the bottom of the dishes. The supernatant containing spermatogonia was recovered, then, after pipetting, put into another 150 mm plastic culture dish coated with collagen, and incubated for further 6 h at 18°C. The recovered supernatant, containing only germ cells (purity was about 90%) was incubated in the absence or presence of FSH (200 ng/ml) for 24 h. The dishes, containing somatic cells, were cultured for 1 week to allow the death of contaminated germ cells and then incubated in the absence and presence of FSH (200 ng/ml) for 24 h.
For reaggregate culture of spermatogonia only, spermatogonia was purified using differential adhesiveness of germ cells and somatic cells to collagen and the recovered germ cells was put through 30 lm nylon mesh filter, centrifuged at 100g for 5 min. After washing with L-15 medium, the reaggregate cultures containing spermatogonia only were prepared as described above.
4.8.
Histology and cell proliferation activity
The cultured testicular fragments and reaggregates were fixed in Bouin solution, dehydrated in graded ethanols, embedded in paraffin and sectioned serially at 5 lm thickness. The sections were treated with xylene, dehydrated in an ethanol series, and stained with Delafield hematoxylin followed by eosin.
For measurement of cell proliferation activity, 5-bromo-2-deoxyuridine (BrdU) was added to the organ culture for 6 h before fixation and detected with a kit according to the manufacturer's instructions (Amersham Pharmacia Biotech, Buckinghamshire, England) as described before (Abé et al., 2002) . The proliferation activity was expressed as a percentage of BrdU-positive cysts among all the cysts in 3 fragments/section · 4 sections each of which was derived from every 5 sections. The average value ± SE was obtained from 3 experiments. The activity in the reaggregate cultures of spermatogonia with somatic cells and of spermatogonia only was measured as a percentage of the number of BrdU-positive spermatogonia among all the living cells within 10 5 lm 2 in a section · 4 sections. The average value ± SE was obtained from 3 experiments.
Statistics
Cell proliferation activities were analyzed by the Student's t test. Probability (P) values <0.05 were considered to be statistically significant.
